Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on the Effects of Dirocaftor, Posenacaftor, and Nesolicaftor for Adults with Cystic Fibrosis
BelgiumStudy on the Safety and Effectiveness of GFH925 and Cetuximab for Patients with Advanced Lung Cancer with KRAS G12C Mutation
GreeceStudy of Tiragolumab, Atezolizumab, and Chemotherapy for Patients with Non-Small Cell Lung Cancer (NSCLC)
GermanyStudy on the Safety and Effectiveness of Filgotinib for Patients with Refractory Behcet's Disease, Idiopathic Inflammatory Myopathies, and IgG4-Related Disease
The NetherlandsStudy on CAL02 and Sodium Chloride for Patients with Severe Community-Acquired Bacterial Pneumonia
BelgiumStudy of Baricitinib for Treating Hospital-Acquired Pneumonia in Critically Ill Patients with a Proinflammatory Profile
BelgiumStudy on Post-Acute COVID-19 Syndrome: Effects of Diet, Exercise, Metformin, and Sirolimus on Frailty and Immune Function in Affected Patients
ItalyStudy on the Effects of Plitidepsin for Adults with Long COVID Symptoms
SpainStudy on the Effectiveness of Paclitaxel, Carboplatin, and Durvalumab for Patients with Extensive Stage Small Cell Lung Cancer
FranceStudy on the Use of 68Ga-EVG321 for Diagnosing Small Cell Lung Cancer in Patients
AustriaStudy on Sildenafil and Hypothermia for Newborns with Hypoxic-Ischemic Encephalopathy
FranceStudy on the Safety of Mercaptamine with Standard Therapy for Hospitalized COVID-19 Pneumonia Patients Not Requiring High Oxygen Flows
ItalyThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
